Very low alpha-fetoprotein in Down syndrome maternal serum screening

Prenatal Diagnosis

Volumn 23, Issue 7, 2003, Pages 584-587

  Muller, Françoise ^a   Dreux, Sophie ^a   Sault, Corinne ^b   Galland, Armelle ^b   Puissant, Hugues ^e   Couplet, Gisèle ^c   Lemay, Catherine ^e   Larcher, Marie Estelle ^d   Renom, Gilles ^e  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LMM Laboratoire Marcel Merieux   (France)

^c Laboratoire Biolille   (France)

^d Laboratoire Stahl Kuntzel   (France)

^e NONE

Author keywords

AFP; Congenital deficiency; Down syndrome screening; Maternal serum markers; Prenatal diagnosis

Indexed keywords

ALPHA FETOPROTEIN; CALCIUM; EDETIC ACID;

ADULT; ANTIBODY DETECTION; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CALCULATION; CELL VIABILITY; DIAGNOSTIC ERROR; DILUTION; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FETUS; FETUS DEATH; FETUS DEVELOPMENT; FLUOROMETRY; HUMAN; INFANCY; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MATERNAL DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; COHORT STUDIES; DEFICIENCY DISEASES; DOWN SYNDROME; FEMALE; FETAL DISEASES; FRANCE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES;

EID: 0042266226     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.646     Document Type: Article

References (19)

1. Aitken DA, McCaw G, Crossley JA, et al. 1993. First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenat Diagn 13: 681-689.
2. Baschat AA, Harman CR, Farid G, Chordiker BN, Evans JA. 2002. Very low second-trimester maternal serum alpha-fetoprotein: association with high birth weight. Obstet Gynecol 99: 531-536.
3. Bennett MJ, Solymar M, Turnbull AC, Cuckle HS, Wald NJ. 1979. Pregnancies associated with low maternal serum alpha-fetoprotein concentrations. Am J Obstet Gynecol 135: 545-546.
4. Cuckle H. 2000. Biochemical screening for Down syndrome. Eur J Obstet Gynecol Reprod Biol 92: 97-101. Review.
5. Davenport DM, Macri JN. 1983. The clinical significance of low maternal serum alpha-fetoprotein. Am J Obstet Gynecol 146: 657-661.
6. Drugan A, Dvorin E, Koppitch FC, Greb A, Krivchenia EL, Evans MI. 1989. Counseling for low maternal serum alpha-fetoprotein emphasize all chromosome anomalies, not just Down syndrome! Obstet Gynecol 73: 271-274.
7. Greenberg F, Faucett A, Rose E, et al. 1992. Congenital deficiency of alpha-protein. Am J Obstet Gynecol 167: 509-511.
8. Haddow JE, Hill LE, Palomaki GE, Knight GJ. 1987. Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death. Prenat Diagn 7: 401-406.
9. Haddow JE, Palomaki GE, Knight GJ, et al. 1992. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med 327: 588-593.
10. Mizejewski GJ. 2001. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp Biol Med 226: 377-408.
11. Muller F, Forestier F, Dingeon B, for ABA Group. 2002a. Second-trimester trisomy 21 maternal serum marker screening. Results of a countrywide study of 854 902 patients. Prenat Diagn 22: 925-929.
12. Muller F, Sault C, Lemay C, Roussel-Mizon N, Forestier F, Frendo JL. 2002b. Second-trimester two-step trisomy 18 screening using maternal serum markers. Prenat Diagn 22: 605-608.
13. Palomaki GE, Knight GJ, McCarthy JE, Haddow JE, Donhowe JM. 1997. Maternal serum screening for Down syndrome in the United States: a 1995 survey. Am J Obstet Gynecol 176: 1046-1051.
14. Sher C, Shohat M. 1997. Congenital deficiency of AFP and Down syndrome screening. Prenat Diagn 17: 884-885.
15. Simpson JL, Baum LD, Depp R, Elias S, Somes G, Marder R. 1987. Low maternal serum alpha-fetoprotein and perinatal outcome. Am J Obstet Gynecol 156: 852-859.
16. Spencer K. 2000. Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review. Br J Obstet Gynaecol 106: 1287-1293.
17. Stein SM, Watt MS, Scrimgeour JB. 1981. Very low maternal plasma alpha-fetoprotein concentration: an indication for follow-up. Br J Obstet Gynaecol 88: 635-639.
18. Wald NJ, Kennard A, Hackshaw A, McGuire A. 1997. Antenatal screening for Down's syndrome. J Med Screen 4: 181-246.
19. Walton DL, Norem CT, Schoen EJ, Ray GT, Colby CJ. 1999. Second-trimester serum chorionic gonadotropin concentrations and complications and outcome of pregnancy. N Engl J Med 341: 2033-2038.